Opko Health Inc (OPK)

$4.13 0.18 (4.56%)

16:44 EST OPK Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 2.31B

PE Ratio -7.25

EPS -0.57

Volume (Avg. Vol.) 4.69M

Day's Range 3.95 - 4.15

52-Week Range 1.12 - 6.47

Dividend & Yield N/A (N/A)

OPK Stock Predictions, Articles, and Opko Health Inc News

From InvestorPlace
From the Web

10 Penny Stocks You’re Better Off Avoiding

By Vince Martin, InvestorPlace Contributor Jul 13, 2020

Penny stocks by nature are risky. These 10 stocks have even higher-than-usual risks, which makes them dangerous for most investors.

Opko Stock Is a Covid-19 Testing Name Worth Betting On

By Larry Ramer, InvestorPlace Contributor Jul 9, 2020

Opko is generating strong revenue from testing for the coronavirus, while its HGH drug looks quite promising. As a result, OPK stock is a buy.

Buy Opko Stock For Two Ways to Play the Ongoing Pandemic

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jul 2, 2020

Opko is conducting a coronavirus treatment study, as well as providing Covid-19 tests. That gives OPK stock two ways to play the virus.

Corporate Insiders Pull the Trigger on These 5 Stocks

By Maya Sasson, Writer, TipRanks Apr 22, 2020

Market watchers are looking to the insiders, hoping insights from their activity can steer them towards returns.

Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test

By William White, InvestorPlace Writer Mar 13, 2020

Roche Holding (RHHBY) news for Friday includes an update on testing for the coronavirus from China with approval from the FDA.

OPKO Health News: Why OPK Health Stock Is Soaring 30% Today

By William White, InvestorPlace Writer Mar 13, 2020

OPKO Health (OPK) news for Friday concerning new testing for the coronavirus from China in New York has OPK stock soaring higher.

OPK Stock Rockets 13% Higher on Coronavirus Test Announcement

By William White, InvestorPlace Writer Mar 6, 2020

Opko Health (OPK) is seeing OPK stock head higher on Friday following an announcement concerning a test for the coronavirus from China.

3 Big Stock Charts for Tuesday: Apple, Scana and Procter & Gamble

By James Brumley, InvestorPlace Feature Writer Nov 13, 2018

Stock charts of AAPL, PG and SCG have earned a closer look from traders as today's session gets started.

7 Biotech Stocks to Buy Now

By Chris Lau, InvestorPlace Contributor Sep 19, 2018

Biotech companies are recovering nicely this year. With a quarter left to go, the upside potential is high for those biotech stocks that dipped recently.

3 Big Stock Charts for Monday: PG&E, Oracle and Weyerhaeuser

By James Brumley, InvestorPlace Feature Writer Sep 17, 2018

The stock charts of PCG, WY and ORCL are run through the technical trading wringer. Here's the next likely move for all three.

OPKO Stock Had a Great Q2 and the Future Looks Even Better

By Chris Lau, InvestorPlace Contributor Aug 8, 2018

With shares nearly double where they were in May, OPKO Health, Inc. (NASDAQ:OPK) needed a strong second-quarter earnings report to justify the gains in OPKO....

Friday’s Vital Data: Nvidia Corporation (NVDA), Netflix, Inc. (NFLX) and Opko Health Inc. (OPK)

By Joseph Hargett, InvestorPlace Contributor Mar 17, 2017

Nvidia (NVDA) options jump on Bosch deal, Bernstein believes in Netflix (NFLX) and Opko Health (OPK) initiated at Guggenheim.

3 Stocks to Buy for Under $10 With 25%-Plus Upside

By Wayne Duggan, InvestorPlace Contributor Feb 13, 2017

Analysts see Rite Aid (RAD), Chesapeake Energy (CHK) and Opko Health (OPK) as three cheap stocks to buy with major near-term upside.

Thursday’s Vital Data: Facebook Inc (FB), Opko Health Inc. (OPK) and Nvidia Corporation (NVDA)

By Joseph Hargett, InvestorPlace Contributor Dec 15, 2016

Facebook (FB) eyes streaming video, Opko Health (OPK) options spike amid kidney drug release and Nvidia (NVDA) upgraded at Evercore ISI.

24 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 28, 2016

This week, the ratings of 24 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

32 Biotechnology Stocks to Sell Now

By Portfolio Grader Nov 21, 2016

This week, the overall grades of 32 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

25 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 3, 2016

25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

3 Big Stock Charts for Tuesday: International Business Machines Corp. (IBM), Amazon.com, Inc. (AMZN) and Opko Health Inc. (OPK)

By Johnson Research Group Aug 9, 2016

Opko Health (OPK), International Business Machines (IBM) and Amazon (AMZN) continue to heat-up the summer trading season by offering chart watchers some attractive bullish breakout opportunities.